Company news

TELA Bio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021

August 15, 2021

TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand

August 10, 2021

TELA Bio to Announce Second Quarter 2021 Financial Results

July 27, 2021

TELA Bio Announces Changes to its Board of Directors

June 1, 2021

TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs

May 24, 2021

TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias

May 18, 2021

TELA Bio Announces First Quarter 2021 Financial Results

May 12, 2021

TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results

March 23, 2021

TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

March 17, 2021

TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

March 1, 2021

TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020

January 13, 2021

TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development

January 4, 2021

TELA Bio Announces Third Quarter 2020 Financial Results

November 10, 2020

TELA Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 11, 2020

October 20, 2020

TELA Bio Presents Additional Data from BRAVO Study of OviTex® for Ventral Hernia Repair

September 24, 2020

TELA Bio Announces Second Quarter 2020 Financial Results

August 11, 2020

TELA Bio to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 12, 2020

July 22, 2020

TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

July 8, 2020

TELA Bio Announces Closing of Public Offering of Common Stock

June 29, 2020

TELA Bio, Inc. to Join the Russell 2000® Index

June 21, 2020

TELA Bio, Inc. Announces Poster Presentations at the 2020 Minimally Invasive Surgery Symposium (MISS)

June 14, 2020

TELA Bio Announces First Quarter 2020 Financial Results

May 11, 2020

TELA Bio to Announce First Quarter 2020 Financial Results and Host Conference Call on May 12, 2020

April 27, 2020

TELA Bio Announces Fourth Quarter and Full Year 2019 Financial Results

March 26, 2020

TELA Bio Announces Publication of Results from In-Vivo Study Demonstrating Favorable Response to Reinforced Biologics in Hernia Repair

February 3, 2020

TELA Bio Announces Appointment of New Chief Commercial Officer

January 28, 2020

TELA Bio Announces Preliminary Revenue for Fourth Quarter and Full Year 2019

January 9, 2020

TELA Bio Announces Third Quarter 2019 Financial Results

December 17, 2019

TELA Bio Awarded Contract with HealthTrust Purchasing Group

December 5, 2019

TELA Bio Appoints Federica O’Brien to Board of Directors

November 12, 2019

TELA Bio Announces Closing of Initial Public Offering of Common Stock

November 12, 2019

TELA Bio Announces Pricing of Initial Public Offering of Common Stock

November 6, 2019

← Newer news releases

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 29 decks. Every deck is listed under its year.